Peripheral artery disease. Part 1: Clinical evaluation and noninvasive diagnosis

Nature Reviews Cardiology

Volumn 8, Issue 7, 2011, Pages 405-418

  Lau, Joe F ^a   Weinberg, Mitchell D ^a   Olin, Jeffrey W ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; D DIMER; HOMOCYSTEINE; LIPOPROTEIN; VITAMIN D;

AFRICAN AMERICAN; AGE; ATHEROSCLEROSIS; CARDIAC PATIENT; CATHETER; CHRONIC KIDNEY DISEASE; COMORBIDITY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; DIGITAL SUBTRACTION ANGIOGRAPHY; DOPPLER ECHOGRAPHY; DYSLIPIDEMIA; ECHOGRAPHY; ETHNICITY; EXERCISE TEST; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; KIDNEY FAILURE; MAGNETIC RESONANCE ANGIOGRAPHY; MORTALITY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NON INVASIVE PROCEDURE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SMOKING; TOBACCO; UNITED STATES;

AGE FACTORS; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; DISEASE PROGRESSION; HUMANS; PERIPHERAL ARTERIAL DISEASE; PROGNOSIS; RISK FACTORS; ULTRASONOGRAPHY, DOPPLER, DUPLEX; UNITED STATES;

EID: 79959630298     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2011.66     Document Type: Review

References (117)

1. Hirsch, A. T. et al. ACC/AHA 2005 Practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Soci Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA task force on practice guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease): Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; Transatlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 113, e463-e654 (2006).
2. Newman, A. B. et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler. Thromb. Vasc. Biol. 19, 538-545 (1999). (Pubitemid 29135153)
3. Hertzer, N. R. et al. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management. Ann. Surg. 199, 223-233 (1984). (Pubitemid 14224577)
4. Hirsch, A. T. et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 286, 1317-1324 (2001). (Pubitemid 33015522)
5. Ruo, B. et al. Persistent depressive symptoms and functional decline among patients with peripheral arterial disease. Psychosom. Med. 69, 415-424 (2007). (Pubitemid 46987884)
6. McDermott, M. M. et al. Functional decline in peripheral arterial disease: Associations with the ankle brachial index and leg symptoms. JAMA 292, 453-461 (2004). (Pubitemid 38988954)
7. McDermott, M. M. et al. Decline in functional performance predicts later increased mobility loss and mortality in peripheral arterial disease. J. Am. Coll. Cardiol. 57, 962-970 (2011).
8. Hirsch, A. T., Gloviczki, P., Drooz, A., Lovell, M. & Creager, M. A. Mandate for creation of a national peripheral arterial disease public awareness program: An opportunity to improve cardiovascular health. J. Vasc. Surg. 39, 474-481 (2004). (Pubitemid 38174339)
9. Baber, U. et al. Combined role of reduced estimated glomerular filtration rate and microalbuminuria on the prevalence of peripheral arterial disease. Am. J. Cardiol. 104, 1446-1451 (2009).
10. Melamed, M. L. et al. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: Results from NHANES 2001 to 2004. Arterioscler. Thromb. Vasc. Biol. 28, 1179-1185 (2008).
11. Kim, D. H., Sabour, S., Sagar, U. N., Adams, S. & Whellan, D. J. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am. J. Cardiol. 102, 1540-1544 (2008).
12. Fung, E. T. et al. A biomarker panel for peripheral arterial disease. Vasc. Med. 13, 217-224 (2008).
13. Wilson, A. M. et al. ß2-microglobulin as a biomarker in peripheral arterial disease: Proteomic profiling and clinical studies. Circulation 116, 1396-1403 (2007). (Pubitemid 47417566)
14. Weinberg, M. D., Lau, J. F., Rosenfield, K. & Olin. J. W. Peripheral artery disease. Part 2: Medical and endovascular treatment. Nat. Rev. Cardiol. doi:10.1038/nrcardio.2011.81.
15. Belch, J. J. et al. Critical issues in peripheral arterial disease detection and management: A call to action. Arch. Intern. Med. 163, 884-892 (2003). (Pubitemid 36519734)
16. Criqui, M. H. et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N. Engl. J. Med. 326, 381-386 (1992).
17. McDermott, M. M. et al. Leg symptoms in peripheral arterial disease: Associated clinical characteristics and functional impairment. JAMA 286, 1599-1606 (2001). (Pubitemid 33010284)
18. Weitz, J. I. et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: A critical review. Circulation 94, 3026-3049 (1996). (Pubitemid 26411793)
19. O'Hare, A. M., Glidden, D. V., Fox, C. S. & Hsu, C. Y. High prevalence of peripheral arterial disease in persons with renal insufficiency: Results from the National Health and Nutrition Examination Survey 1999-2000. Circulation 109, 320-323 (2004). (Pubitemid 38133897)
20. McDermott, M. M. et al. Asymptomatic peripheral arterial disease is associated with more adverse lower extremity characteristics than intermittent claudication. Circulation 117, 2484-2491 (2008). (Pubitemid 351670455)
21. McDermott, M. M. et al. Prognostic value of functional performance for mortality in patients with peripheral artery disease. J. Am. Coll. Cardiol. 51, 1482-1489 (2008). (Pubitemid 351492522)
22. Heald, C. L., Fowkes, F. G., Murray, G. D. & Price, J. F. Risk of mortality and cardiovascular disease associated with the ankle-brachial index: Systematic review. Atherosclerosis 189, 61-69 (2006). (Pubitemid 44441297)
23. Doobay, A. V. & Anand, S. S. Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: A systematic review. Arterioscler. Thromb. Vasc. Biol. 25, 1463-1469 (2005). (Pubitemid 40923369)
24. Resnick, H. E. et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: The Strong Heart Study. Circulation 109, 733-739 (2004). (Pubitemid 38222892)
25. Diehm, C. et al. High prevalence of peripheral arterial disease and co-morbidity in 6,880 primary care patients: Cross-sectional study. Atherosclerosis 172, 95-105 (2004). (Pubitemid 38058606)
26. Diehm, C. et al. Association of low ankle brachial index with high mortality in primary care. Eur. Heart J. 27, 1743-1749 (2006). (Pubitemid 44025363)
27. McDermott, M. M., Feinglass, J., Slavensky, R. & Pearce, W. H. The ankle-brachial index as a predictor of survival in patients with peripheral vascular disease. J. Gen. Intern. Med. 9, 445-449 (1994). (Pubitemid 24258782)
28. Thatipelli, M. R. et al. Prognostic value of ankle-brachial index and dobutamine stress echocardiography for cardiovascular morbidity and all-cause mortality in patients with peripheral arterial disease. J. Vasc. Surg. 46, 62-70 (2007). (Pubitemid 46990758)
29. McKenna, M., Wolfson, S. & Kuller, L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis 87, 119-128 (1991).
30. Fowkes, F. G. et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: A meta-analysis. JAMA 300, 197-208 (2008). (Pubitemid 351969304)
31. O'Hare, A. M., Katz, R., Shlipak, M. G., Cushman, M. & Newman, A. B. Mortality and cardiovascular risk across the ankle-arm index spectrum: Results from the Cardiovascular Health Study. Circulation 113, 388-393 (2006). (Pubitemid 43803200)
32. Shlipak, M. G. et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann. Intern. Med. 145, 237-246 (2006). (Pubitemid 46768607)
33. Bonham, P. A. Photo guide: Determining the toe brachial pressure index. Nursing 33, 54-55 (2003).
34. Cooke, J. P. & Wilson, A. M. Biomarkers of peripheral arterial disease. J. Am. Coll. Cardiol. 55, 2017-2023 (2010).
35. Shlipak, M. G. et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N. Engl. J. Med. 352, 2049-2060 (2005). (Pubitemid 40664306)
36. Murabito, J. M., D'Agostino, R. B., Silbershatz, H. & Wilson, W. F. Intermittent claudication. A risk profile from The Framingham Heart Study. Circulation 96, 44-49 (1997). (Pubitemid 27298402)
37. Selvin, E. & Erlinger, T. P. Prevalence of and risk factors for peripheral arterial disease in the United States: Results from the National Health and Nutrition Examination Survey, 1999-2000 Circulation 110, 738-743 (2004). (Pubitemid 39056275)
38. Wattanakit, K. et al. Risk factors for peripheral arterial disease incidence in persons with diabetes: The Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 180, 389-397 (2005). (Pubitemid 41072911)
39. Newman, A. B. et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation 88, 837-845 (1993). (Pubitemid 23263998)
40. Dormandy, J. A. & Rutherford, R. B. Management of peripheral arterial disease (PAD). TASC Working Group. Transatlantic Inter-Society Consensus (TASC). J. Vasc. Surg. 31, S1-S296 (2000).
41. Smith, S. C. Jr. et al. Atherosclerotic Vascular Disease Conference: Writing Group II: Risk factors. Circulation 109, 2613-2616 (2004). (Pubitemid 38720565)
42. Levy, P. J. Epidemiology and pathophysiology of peripheral arterial disease. Clin. Cornerstone 4, 1-15 (2002).
43. Newman, A. B., Sutton-Tyrrell, K., Vogt, M. T. & Kuller, L. H. Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. JAMA 270, 487-489 (1993). (Pubitemid 23223487)
44. Ix, J. H., Allison, M. A., Denenberg, J. O., Cushman, M. & Criqui, M. H. Novel cardiovascular risk factors do not completely explain the higher prevalence of peripheral arterial disease among African Americans. The San Diego Population Study. J. Am. Coll. Cardiol. 51, 2347-2354 (2008). (Pubitemid 351783358)
45. McDermott, M. M. et al. Ankle-brachial index and subclinical cardiac and carotid disease: The multi-ethnic study of atherosclerosis. Am. J. Epidemiol. 162, 33-41 (2005). (Pubitemid 40884998)
46. Fowkes, F. G. et al. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am. J. Epidemiol. 135, 331-340 (1992).
47. Kannel, W. B. & Shurtleff, D. The Framingham Study. Cigarettes and the development of intermittent claudication. Geriatrics 28, 61-68 (1973).
48. Powell, J. T. et al. Risk factors associated with the development of peripheral arterial disease in smokers: A case-control study. Atherosclerosis 129, 41-48 (1997). (Pubitemid 27104248)
49. Price, J. F. et al. Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study. Eur. Heart J. 20, 344-353 (1999). (Pubitemid 29103732)
50. Willigendael, E. M. et al. Smoking and the patency of lower extremity bypass grafts: A meta-analysis. J. Vasc. Surg. 42, 67-74 (2005). (Pubitemid 40966078)
51. Jonason, T. & Bergström, R. Cessation of smoking in patients with intermittent claudication. Effects on the risk of peripheral vascular complications, myocardial infarction and mortality. Acta Med. Scand. 221, 253-260 (1987). (Pubitemid 17069424)
52. Pande, R. L., Perlstein, T. S., Beckman, J. A. & Creager, M. A. Association of insulin resistance and inflammation with peripheral arterial disease: The National Health and Nutrition Examination Survey, 1999 to 2004. Circulation 118, 33-41 (2008).
53. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care 26, 3333-3341 (2003).
54. Jude, E. B., Oyibo, S. O., Chalmers, N. & Boulton, A. J. Peripheral arterial disease in diabetic and nondiabetic patients: A comparison of severity and outcome. Diabetes Care 24, 1433-1437 (2001). (Pubitemid 33716433)
55. Conrad, M. C. Large and small artery occlusion in diabetics and nondiabetics with severe vascular disease. Circulation 36, 83-91 (1967).
56. Menzoian, J. O. et al. Symptomatology and anatomic patterns of peripheral vascular disease: Differing impact of smoking and diabetes. Ann. Vasc. Surg. 3, 224-228 (1989).
57. Akbari, C. M. & LoGerfo, F. W. Diabetes and peripheral vascular disease. J. Vasc. Surg. 30, 373-384 (1999). (Pubitemid 29395412)
58. Most, R. S. & Sinnock, P. The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care 6, 87-91 (1983). (Pubitemid 13144888)
59. Bild, D. E. et al. Lower-extremity amputation in people with diabetes. Epidemiology and prevention. Diabetes Care 12, 24-31 (1989). (Pubitemid 19029811)
60. Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285, 2486-2497 (2001).
61. Grundy, S. M. et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110, 227-239 (2004). (Pubitemid 38924592)
62. Olin, J. W. & Sealove, B. A. Peripheral artery disease: Current insight into the disease and its diagnosis and management. Mayo Clin. Proc. 85, 678-692 (2010).
63. Steg, P. G. et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 297, 1197-1206 (2007).
64. Chobanian, A. V. et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42, 1206-1252 (2003). (Pubitemid 37553153)
65. Newman, A. B., Tyrrell, K. S. & Kuller, L. H. Mortality over four years in SHEP participants with a low ankle-arm index. J. Am. Geriatr. Soc. 45, 1472-1478 (1997). (Pubitemid 27523123)
66. Shlipak, M. G. et al. Cardiovascular disease risk status in elderly persons with renal insufficiency. Kidney Int. 62, 997-1004 (2002). (Pubitemid 35316730)
67. Wattanakit, K. et al. Kidney function and risk of peripheral arterial disease: Results from the Atherosclerosis Risk in Communities (ARIC) Study. J. Am. Soc. Nephrol. 18, 629-636 (2007). (Pubitemid 46193329)
68. O'Hare, A. M. Management of peripheral arterial disease in chronic kidney disease. Cardiol. Clin. 23, 225-236 (2005). (Pubitemid 41097348)
69. Ix, J. H. & Criqui, M. H. Epidemiology and diagnosis of peripheral arterial disease in patients with chronic kidney disease. Adv. Chronic Kidney Dis. 15, 378-383 (2008).
70. Reddy Vanga, S., Good, M., Howard, P. A. & Vacek, J. L. Role of vitamin D in cardiovascular health. Am. J. Cardiol. 106, 798-805 (2010).
71. Lee, J. H., O'Keefe, J. H., Bell, D., Hensrud, D. D. & Holick, M. F. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J. Am. Coll. Cardiol. 52, 1949-1956 (2008).
72. Reis, J. P., Michos, E. D., von Muhlen, D. & Miller, E. R. 3rd. Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease. Am. J. Clin. Nutr. 88, 1469-1477 (2008).
73. McDermott, M. M. et al. Patterns of inflammation associated with peripheral arterial disease: The InCHIANTI study. Am. Heart J. 150, 276-281 (2005). (Pubitemid 41116253)
74. Ridker, P. M., Stampfer, M. J. & Rifai, N. Novel risk factors for systemic atherosclerosis: A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 285, 2481-2485 (2001). (Pubitemid 32433842)
75. Vidula, H. et al. Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: A cohort study. Ann. Intern. Med. 148, 85-93 (2008). (Pubitemid 351651551)
76. Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P. & Hennekens, C. H. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 97, 425-428 (1998). (Pubitemid 28090212)
77. Wildman, R. P., Muntner, P., Chen, J., Sutton-Tyrrell, K. & He, J. Relation of inflammation to peripheral arterial disease in the National Health and Nutrition Examination Survey, 1999-2002 Am. J. Cardiol. 96, 1579-1583 (2005). (Pubitemid 41690183)
78. Welch, G. N. & Loscalzo, J. Homocysteine and atherothrombosis. N. Engl. J. Med. 338, 1042-1050 (1998). (Pubitemid 128753793)
79. Lange, S. et al. Excess 1-year cardiovascular risk in elderly primary care patients with a low ankle-brachial index (ABI) and high homocysteine level. Atherosclerosis 178, 351-357 (2005). (Pubitemid 40193451)
80. Murabito, J. M. et al. Cross-sectional relations of multiple inflammatory biomarkers to peripheral arterial disease: The Framingham Offspring Study. Atherosclerosis 203, 509-514 (2009).
81. McDermott, M. M. et al. Associations of borderline and low normal ankle-brachial index values with functional decline at 5-year follow-up: The WALCS (Walking and Leg Circulation Study). J. Am. Coll. Cardiol. 53, 1056-1062 (2009).
82. Craft, L. L. et al. Physical activity during daily life and circulating biomarker levels in patients with peripheral arterial disease. Am. J. Cardiol. 102, 1263-1268 (2008).
83. Knowles, J. W., Assimes, T. L., Li, J., Quertermous, T. & Cooke, J. P. Genetic susceptibility to peripheral arterial disease: A dark corner in vascular biology. Arterioscler. Thromb. Vasc. Biol. 27, 2068-2078 (2007). (Pubitemid 350287233)
84. Olin, J. W. Management of patients with intermittent claudication. Int. J. Clin. Pract. 56, 687-693 (2002). (Pubitemid 35422614)
85. Brueseke, T. J., Macrino, S. & Miller, J. J. Lack of lower extremity hair not a predictor for peripheral arterial disease. Arch. Dermatol. 145, 1456-1457 (2009).
86. Carter, S. A. Indirect systolic pressures and pulse waves in arterial occlusive diseases of the lower extremities. Circulation 37, 624-637 (1968).
87. Carter, S. A. Clinical measurement of systolic pressures in limbs with arterial occlusive disease. JAMA 207, 1869-1874 (1969).
88. Yao, S. T. Hemodynamic studies in peripheral arterial disease. Br. J. Surg. 57, 761-766 (1970).
89. Strandness, D. E. Jr, Schultz, R. D., Sumner, D. S. & Rushmer, R. F. Ultrasonic flow detection. A useful technic in the evaluation of peripheral vascular disease. Am. J. Surg. 113, 311-320 (1967).
90. Wütschert, R. & Bounameaux, H. Predicting healing of arterial leg ulcers by means of segmental systolic pressure measurements. Vasa 27, 224-228 (1998). (Pubitemid 28525265)
91. Hafner, J. et al. Leg ulcers in peripheral arterial disease (arterial leg ulcers): Impaired wound healing above the threshold of chronic critical limb ischemia. J. Am. Acad. Dermatol. 43, 1001-1008 (2000).
92. Wolf, E. A. Jr, Sumner, D. S. & Strandness, D. E. Jr. Correlation between nutritive blood flow and pressure in limbs of patients with intermittent claudication. Surg. Forum 23, 238-239 (1972).
93. Darling, R. C., Raines, J. K., Brener, B. J. & Austen, W. G. Quantitative segmental pulse volume recorder: A clinical tool. Surgery 72, 873-877 (1972).
94. Macdonald, N. Pulse volume plethysmography. J. Vasc. Tech. 18, 241-248 (1994). (Pubitemid 24377972)
95. Moneta, G. L. et al. Accuracy of lower extremity arterial duplex mapping. J. Vasc. Surg. 15, 275-283 (1992).
96. Grønholdt, M. L. B-mode ultrasound and spiral CT for the assessment of carotid atherosclerosis. Neuroimaging Clin. N. Am. 12, 421-435 (2002).
97. Tang, R., Mercuri, M. & Bond, M. G. B-mode ultrasound imaging for detecting and monitoring peripheral atherosclerosis. Am. J. Card. Imaging 6, 333-339 (1992). (Pubitemid 23035460)
98. Hatsukami, T. S., Primozich, J. F., Zierler, R. E., Harley, J. D. & Strandness, D. E. Jr. Color Doppler imaging of infrainguinal arterial occlusive disease. J. Vasc. Surg. 16, 527-531 (1992).
99. Ligush, J. Jr, Reavis, S. W., Preisser, J. S. & Hansen, K. J. Duplex ultrasound scanning defines operative strategies for patients with limb-threatening ischemia. J. Vasc. Surg. 28, 482-490 (1998).
100. Schernthaner, R. et al. Multidetector CT angiography in the assessment of peripheral arterial occlusive disease: Accuracy in detecting the severity, number, and length of stenoses. Eur. Radiol. 18, 665-671 (2008).
101. Laswed, T. et al. Assessment of occlusive arterial disease of abdominal aorta and lower extremities arteries: Value of multidetector CT angiography using an adaptive acquisition method. Eur. Radiol. 18, 263-272 (2008). (Pubitemid 351234045)
102. Met, R., Bipat, S., Legemate, D. A., Reekers, J. A. & Koelemay, M. J. Diagnostic performance of computed tomography angiography in peripheral arterial disease: A systematic review and meta-analysis. JAMA 301, 415-424 (2009).
103. von Ziegler, F. & Costa, M. A. The role of CT and MRI in the assessment of peripheral vascular disease. Curr. Cardiol. Rep. 9, 412-419 (2007). (Pubitemid 47370820)
104. Keeling, A., Farrelly, C., Carr, J. & Yaghmai, V. Technical considerations for lower limb multi-detector computed tomographic angiography. Vasc. Med. doi:10.1177/1358863X10388347.
105. Martin, M. L. et al. Multidetector CT angiography of the aortoiliac system and lower extremities: A prospective comparison with digital subtraction angiography. AJR Am. J. Roentgenol. 180, 1085-1091 (2003). (Pubitemid 36363055)
106. Catalano, C. et al. Infrarenal aortic and lower-extremity arterial disease: Diagnostic performance of multi-detector row CT angiography. Radiology 231, 555-563 (2004). (Pubitemid 38552917)
107. Willmann, J. K. et al. Aortoiliac and lower extremity arteries assessed with 16-detector row CT angiography: Prospective comparison with digital subtraction angiography. Radiology 236, 1083-1093 (2005). (Pubitemid 41170877)
108. Brockmann, C. et al. Dual-energy CT angiography in peripheral arterial occlusive disease. Cardiovasc. Intervent. Radiol. 32, 630-637 (2009).
109. Meyer, B. C. et al. Dual energy CT of peripheral arteries: Effect of automatic bone and plaque removal on image quality and grading of stenoses. Eur. J. Radiol. 68, 414-422 (2008).
110. Leiner, T. Magnetic resonance angiography of abdominal and lower extremity vasculature. Top. Magn. Reson. Imaging 16, 21-66 (2005). (Pubitemid 43186777)
111. Collins, R. et al. Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease: Systematic review. BMJ 334, 1257 (2007).
112. Kramer, H., Nikolaou, K., Sommer, W., Reiser, M. F. & Herrmann, K. A. Peripheral MR angiography. Magn. Reson. Imaging Clin. N. Am. 17, 91-100 (2009).
113. Huber, A. et al. Moving-table MR angiography of the peripheral runoff vessels: Comparison of body coil and dedicated phased array coil systems. AJR Am. J. Roentgenol. 180, 1365-1373 (2003). (Pubitemid 36504629)
114. Kribben, A. et al. Nephrogenic systemic fibrosis: Pathogenesis, diagnosis, and therapy. J. Am. Coll. Cardiol. 53, 1621-1628 (2009).
115. Perazella, M. A. Current status of gadolinium toxicity in patients with kidney disease. Clin. J. Am. Soc. Nephrol. 4, 461-469 (2009).
116. Prince, M. R. et al. Incidence of nephrogenic systemic fibrosis at two large medical centers. Radiology 248, 807-816 (2008).
117. Olin, J. W. in Noninvasive cardiovascular imaging: A multimodality approach 1st edn (ed. Garcia, M. J.), 252-268 (Lippincott Williams & Wilkins, Philadelphia, 2010).